Search SMG
SCOTTS MIRACLE-GRO CO
NYSE · CIK 825542
Last close49.02
Daily change-1.00 (-2.00%)
10 Years gain-5.51%
Dividends TTM2.64 (+0.00%)
Dividend yield5.28%
Fundamental Analysis
SMG · STANDARD
SIC 2870 · Agricultural Chemicals · Fiscal year end 0930
Fundamental
63.7Momentum
56.5Acceleration
61.9Confidence
100.0Annual Revenue19
Quarterly Revenue79
Annual CFO18
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth3.8 / 25
Quality22.0 / 25
Capital Efficiency19.9 / 20
Balance Sheet7.6 / 15
Shareholder Economics7.2 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 2.3828 percentage points.
Operating leverageOperating margin improved by 1.3004 percentage points.
FCF growthFree cash flow grew 0.2993%.
ROIC expansionROIC improved by 3.9946 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM-7.55%OK
Revenue CAGR 3Y-4.54%OK
Gross Margin34.69%OK
Operating Margin18.61%OK
FCF Margin13.74%OK
FCF Growth0.3%OK
ROIC24.68%OK
Incremental Operating Margin 3Y24,108.7%OK
Net Debt / CFO3.21xOK
Diluted Share Growth 1Y1.37%OK
SBC / Revenue1.35%OK
SBC / FCF9.8%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Sep 30, 2025 | $3.41B | $1.04B | $358.60M | $371.30M | $273.90M | 30.59% | 10.51% | 8.03% | 13.52% | 58.7M |
| 2025 FY Sep 30, 2024 | $3.55B | $850.50M | $208.80M | $667.50M | $583.50M | 23.94% | 5.88% | 16.42% | 8.09% | 56.8M |
| 2025 FY Sep 30, 2023 | $3.55B | $657.30M | -$174.40M | $531.00M | $438.20M | 18.51% | -4.91% | 12.34% | -5.16% | 56M |
| 2024 FY Sep 30, 2022 | $3.92B | $872.90M | -$434.00M | -$129.00M | -$242.50M | 22.24% | -11.06% | -6.18% | -11.29% | 55.5M |
| 2023 FY Sep 30, 2021 | $4.93B | $1.47B | $723.00M | $271.50M | $164.60M | 29.83% | 14.68% | 3.34% | 21.14% | 57.2M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $4.15B | sum latest 4 fiscal quarters Revenue | OK | 0000825542-26-000041, 0000825542-26-000008 |
| Revenue Growth TTM | -7.55% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000825542-26-000041, 0000825542-26-000008 |
| Revenue CAGR 3Y | -4.54% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000825542-25-000022 |
| Revenue CAGR 5Y | -3.75% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000825542-25-000022 |
| Gross Profit CAGR 3Y | 6.15% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000825542-25-000022 |
| Operating Income Growth | -0.61% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0000825542-26-000041, 0000825542-26-000008 |
| FCF Growth | 0.3% | FCF_current / FCF_prior_year - 1 | OK | 0000825542-26-000041, 0000825542-26-000024 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 34.69% | Gross Profit / Revenue | OK | 0000825542-26-000041, 0000825542-26-000008 |
| Operating Margin | 18.61% | Operating Income / Revenue | OK | 0000825542-26-000041, 0000825542-26-000008 |
| FCF Margin | 13.74% | (CFO - CapEx) / Revenue | OK | 0000825542-26-000041, 0000825542-26-000024 |
| CFO / Net Income | 1.73x | CFO / Net Income | OK | 0000825542-26-000041, 0000825542-26-000024 |
| FCF / Net Income | 1.52x | FCF / Net Income | OK | 0000825542-26-000041, 0000825542-26-000024 |
| ROIC | 24.68% | NOPAT / Average Invested Capital | OK | 0000825542-26-000041, 0000825542-26-000008 |
| Net Debt / CFO | 3.21x | Net Debt / CFO | OK | 0000825542-26-000041, 0000825542-26-000024 |